Company intelligence / Profile preview

Agreen Biosolutions

Ownership: Private
Development stage: Preclinical

Overview

Agreen Biosolutions develops fully organic, ozonated oil-based active ingredients as alternatives to chemical pesticides. Their proprietary technology enables the production of these bioactive compounds to support sustainable farming practices. The company’s solutions aim to replicate and replace traditional chemical crop protectants with environmentally friendly options.

Modalities: Ozonated oil-based bioproducts for plant protection
Industry: Agriculture & AgTech

Drug pipeline

1 asset

OZ.ON

Pre-clinical

Indications: Crop protection, Plant nutrition

Beyond the preview

Go deeper on Agreen Biosolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agreen Biosolutions.

Explore the full profile